This inventor holds 1 USPTO granted patent and 3 published patent applications and 4 EPO patents. Top assignee: Zhejiang Yangshengtang Institute of Natural Medication Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Quan Han
Introduction
Quan Han is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of natural medication, particularly in the area of diabetes treatment. His work focuses on the development of innovative combination products that leverage the benefits of various compounds.
Latest Patents
Quan Han holds a patent for a combination product containing a limonoid compound and a biguanide compound. This invention relates to a combination product comprising a limonoid compound, or a pharmaceutically acceptable derivative, ester, stereoisomer, salt, or prodrug thereof, and a biguanide compound such as metformin, metformin hydrochloride, buformin, and phenformin. The patent outlines the use of this combination product for the prevention and/or treatment of diseases associated with diabetes, as well as for lipid-lowering and weight-loss purposes.
Career Highlights
Quan Han is affiliated with the Zhejiang Yangshengtang Institute of Natural Medication Co., Ltd. His work at this institute has allowed him to focus on the intersection of natural compounds and modern medicine, contributing to advancements in therapeutic options for patients.
Collaborations
Quan Han collaborates with Dong Li, a fellow researcher, to further explore the potential applications of his inventions in the medical field.
Conclusion
Quan Han's innovative work in developing combination products for diabetes treatment showcases his commitment to improving health outcomes through scientific research. His contributions are paving the way for new therapeutic options in the field of natural medication.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile